Effects, Tolerance, and Response to COVID-19 Vaccines in Hispanic Puerto Rican Patients with Multiple Sclerosis
Background: At the start of the SARS-CoV-2 (COVID-19) pandemic there was uncertainty among Multiple Sclerosis (MS) patients about starting...
Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes
Background: There are more than 20 disease modifying therapies (DMTs) approved for treatment of Multiple Sclerosis. Previous studies in the...
Longitudinal Olfactory Patterns in Multiple Sclerosis: A Scoping Review and Implications for Use in Management of Disease
Background: Previous studies reviewing the presence of olfactory dysfunction (OD) in Multiple Sclerosis (MS) have focused on the prevalence...
Oligoclonal Band Negative Multiple Sclerosis in Puerto Rico
Background: The incidence of multiple sclerosis (MS) in Puerto Rico (PR) is higher than in other Latin American and Caribbean countries....
Evidence of Distress By Multiple Sclerosis (MS) Patient Caregiver As a Consequence of COVID-19
Background: Multiple Sclerosis (MS) is a demyelinating condition that leads to progressive weakness and disability often resulting in...
Demographic and Clinical Associations with Neuromyelitis Optica Spectrum Disorder in an Academic Medical Center
Background: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare, inflammatory CNS syndrome, which, left untreated, may result in...
Importance of Cervical Magnetic Resonance Imaging in the Diagnosis, Treatment, and Monitoring of Hispanic Puerto Rican Multiple Sclerosis Patients
Background: Some Health Insurances in Puerto Rico (PR) limit the number of magnetic resonance imaging (MRI) procedures that can be done in...